Wayne Moore
Physician · Children's Mercy Hospital
Credentials: · · ·
History
2022–Present
- 1973–1975
Endocrinology, Diabetes, and Metabolism
- 1970–1973
Internal Medicine
Research
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
New England Journal of Medicine · 2019 · 918 citations
Journal of Clinical Investigation · 2015 · 254 citations
Growth hormone therapy of Turner's syndrome: beneficial effect on adult height
The Journal of Pediatrics · 1998 · 194 citations
10 papers
9 papers
- TW
8 papers
- CG
7 papers
7 papers
7 papers
- AC
6 papers
6 papers
Grants
- 2015–2020
Type 1 Diabetes TrialNet Clinical Centers - Kansas City
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $1.5M · Children's Mercy Hosp (Kansas City, Mo)
- 1987–1990
Combined Islet and Renal Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $339K · University of Kansas Medical Center
Clinical trials
- 2009–2010
Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
Principal investigator · Completed
Children's Mercy Hospital Kansas City
- 2006–2009
Molecular Quantification of Insulin mRNA
Principal investigator · Completed
Children's Mercy Hospital Kansas City
- 2005–2013
Adrenocorticotropic Hormone (ACTH) Stimulation and G Protein
Study chair · Completed
Children's Mercy Hospital Kansas City
- 2025–2027
Site PI · Recruiting · Phase 1, Phase 2
COUR Pharmaceutical Development Company, Inc.